NOVARTIS INDIA
Back to Balance Sheet
|
NOVARTIS INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-15 Cr | ₹-16 Cr | ₹-27 Cr | ₹-30 Cr | ₹-25 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NOVARTIS INDIA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-15 Cr |
Mar2023 | ₹-16 Cr |
Mar2022 | ₹-27 Cr |
Mar2021 | ₹-30 Cr |
Mar2020 | ₹-25 Cr |
How is Deferred Tax Assets / Liabilities of NOVARTIS INDIA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-15 Cr | Negative | |
Mar2023 | ₹-16 Cr | Negative | |
Mar2022 | ₹-27 Cr | Negative | |
Mar2021 | ₹-30 Cr | Negative | |
Mar2020 | ₹-25 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NOVARTIS INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NOVARTIS INDIA | ₹2,109.0 Cr | -4.3% | -7.5% | -14% | Stock Analytics | |
ADANI ENTERPRISES | ₹261,814.0 Cr | -0.8% | -11.6% | -27.1% | Stock Analytics | |
REDINGTON | ₹15,940.4 Cr | 0.2% | 1.1% | 15% | Stock Analytics | |
MMTC | ₹10,150.5 Cr | 4.4% | -9.2% | -14.4% | Stock Analytics | |
HONASA CONSUMER | ₹7,436.9 Cr | 1.9% | -9.3% | -52.9% | Stock Analytics | |
MSTC | ₹4,242.7 Cr | 7.3% | -12.4% | -42.2% | Stock Analytics |
NOVARTIS INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | -4.3% |
-7.5% |
-14% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses